Daily Dose - Oct 24th, 2025
Daily Dose |
View online
October 24, 2025
Editor’s (re)View: Lonza and Thermo Fisher roll on despite volatility in business environment
The two bellwethers of the CDMO industry reported strong financial results for the third quarter of 2025 amid uncertainty in geopolitics and funding.
Read More
Galderma to invest $650M in US manufacturing expansion
The Swiss dermatology company plans to ramp up production of key brands including Nemluvio, Alastin and Cetaphil through U.S.-based contract manufacturing partners.
Read More
Serán BioScience expands commercial manufacturing in Oregon
The new 100,000-square-foot campus in Bend will enhance Serán’s U.S. production capacity for small molecule therapeutics.
Read More